AbbVie, a worldwide biopharmaceutical company, recently granted scholarships to students from the company’s Crohn’s & Colitis Scholarship as well as the AbbVie Rheumatology Scholarship.
This year, 30 students received scholarships, amounting to $15,000 for each student’s higher education. All of the recipients are exceptional students who have inflammatory bowel diseases like ulcerative colitis, Crohn’s disease, juvenile idiopathic arthritis, ankylosing spondylitis, rheumatoid arthritis and psoriatic arthritis. The students will be able to invest this financial assistance in their higher education.
Recipients were chosen because of their academic excellence, written responses to essay questions, involvement in their communities and service as positive examples in their local areas.
Students who have chronic inflammatory diseases typically face many challenges during higher education. These challenges include difficulty sitting during exams and missing school.
"Chronic inflammatory diseases may bring challenges that can impact a student's pursuit of higher education," Tracie Haas, vice president corporate responsibility, brand and communications for AbbVie, said. "Transforming education is a cornerstone of AbbVie's corporate responsibility practices. We are proud to honor these exceptional students and committed to providing the resources to them today, so they are prepared to succeed tomorrow."
The scholarships will pay for the students’ undergraduate or graduate degree, trade school diploma or an associate's degree. Students must be attending an accredited U.S. college, university or trade school to qualify for the scholarships.
